Enochian BioSciences Revenue and Competitors
Estimated Revenue & Valuation
- Enochian BioSciences's estimated annual revenue is currently $3.3M per year.
- Enochian BioSciences's estimated revenue per employee is $155,000
Employee Data
- Enochian BioSciences has 21 Employees.
- Enochian BioSciences grew their employee count by -22% last year.
Enochian BioSciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & Director | Reveal Email/Phone |
2 | Head Molecular Biology | Reveal Email/Phone |
3 | SVP, Clinical Operations | Reveal Email/Phone |
4 | Chief Financial Officer & Corporate Secretary | Reveal Email/Phone |
5 | Research Associate | Reveal Email/Phone |
Enochian BioSciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Enochian BioSciences?
Enochian BioSciences (formerly DanDrit Biotech USA Inc.) a biopharmaceutical company, focuses on the development and commercialization of novel therapies aimed to change the course of immunotherapy treatments for HIV/AIDS and cancer. The company's lead candidate ENO-1001 (pre-IND) is a potentially sterilizing cure for HIV/AIDS. ENO-2001 is an HIV vaccine in preclinical stage, and its additional compounds ENO-4001 (phase three asset), ENO-4002, ENO-5001, and ENO-3001 are in discovery stages for prevention relapse in colon cancer patients. Enochian BioSciences is headquartered in Los Angeles, California.
keywords:N/A
N/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Enochian BioSciences News
Enochian BioSciences Announces the Appointment of Executive Vice President of Research and Development with 25 years of Industry Experience.
LOS ANGELES, April 07, 2022 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., (NASDAQ: ENOB), a company focused on gene-modified cellular and...
LOS ANGELES, April 05, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) Enochian BioSciences, a company focused on gene-modified cellular and...
Other Companies in Los Angeles
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 21 | N/A | N/A |
#2 | $2.1M | 21 | N/A | N/A |
#3 | $2.1M | 21 | N/A | N/A |
#4 | $2.1M | 21 | N/A | N/A |
#5 | $1.5M | 21 | -5% | $5.8M |